Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Better reports on the significance of 10-year T-notes in predicting mortgage rates and the Fed's upcoming decisions amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback